Identification of a functional NF-κB site in the platelet endothelial cell adhesion molecule-1 promoter

被引:30
作者
Botella, LM
Puig-Kröger, A
Almendro, N
Sánchez-Elsner, T
Muñoz, E
Corbí, A
Bernabéu, C
机构
[1] CSIC, Ctr Invest Biol, E-28006 Madrid, Spain
[2] Univ Cordoba, Fac Med, Dept Fis Immunol, E-14071 Cordoba, Spain
关键词
D O I
10.4049/jimmunol.164.3.1372
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a type I transmembrane adhesion protein of 130 kDa that belongs to a subgroup of the Ig gene superfamily, characterized by the presence of immunoreceptor tyrosine-based inhibitory motifs, PECAM-1 is expressed in circulating platelets, monocytes, neutrophils, a selective subgroup of T cells, and in endothelial cells, where it is preferentially located at intercellular junctions and participates in leukocyte transmigratory processes. The identification of two consensus NF-kappa B sites within the PECAM-1 promoter led us to analyze their possible involvement in the PECAM-1 expression regulated by inflammatory; stimuli. We found that surface expression and promoter activity of PECAM-1 in myeloid cells are regulated by modulators of NF-kappa B, including TNF-alpha, PMA, and pyrrolidine dithiocarbamate, Mobility shifts assays identified a specific NF-kappa B-binding element at +110/+120, whose mutation abolished the basal promoter activity of PECAM-1 and decreased NF-kappa B-dependent responses of the PECAM-1 gene promoter. Furthermore, cotransfection experiments with an expression vector encoding the p65 subunit of NF-kappa B showed transactivation of the PECAM-1 promoter. These results demonstrate that NF-kappa B can regulate the transcriptional activity of PECAM-1.
引用
收藏
页码:1372 / 1378
页数:7
相关论文
共 36 条
[1]  
Almendro N, 1996, J IMMUNOL, V157, P5411
[2]   Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage [J].
Aragones, J ;
LopezRodriquez, C ;
Corbi, A ;
delArco, PG ;
LopezCabrera, M ;
deLandazuri, MO ;
Redondo, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10924-10931
[3]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[4]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[5]   PURIFICATION OF CACHECTIN, A LIPOPROTEIN-LIPASE SUPPRESSING HORMONE SECRETED BY ENDOTOXIN-INDUCED RAW 264.7 CELLS [J].
BEUTLER, B ;
MAHONEY, J ;
LETRANG, N ;
PEKALA, P ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :984-995
[6]  
Buckley CD, 1996, J CELL SCI, V109, P437
[7]   CHARACTERIZATION OF A NOVEL MYELOID ANTIGEN REGULATED DURING DIFFERENTIATION OF MONOCYTIC CELLS [J].
CABANAS, C ;
SANCHEZMADRID, F ;
BELLON, T ;
FIGDOR, CG ;
VELDE, AAT ;
FERNANDEZ, JM ;
ACEVEDO, A ;
BERNABEU, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) :1373-1378
[8]  
CARLOS TM, 1994, BLOOD, V84, P2068
[9]  
ChristofidouSolomidou M, 1997, J IMMUNOL, V158, P4872
[10]   TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS [J].
COLLINS, T ;
READ, MA ;
NEISH, AS ;
WHITLEY, MZ ;
THANOS, D ;
MANIATIS, T .
FASEB JOURNAL, 1995, 9 (10) :899-909